Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?
Fiche publication
Date publication
août 2022
Journal
Cancers
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BORG Christophe, Dr VERNEREY Dewi, Pr BOULAHDOUR Hatem, Mme HENRIQUES Julie, Mr FALCOZ Antoine
Tous les auteurs :
De Bari B, Lefevre L, Henriques J, Gatta R, Falcoz A, Mathieu P, Borg C, Dinapoli N, Boulahdour H, Boldrini L, Valentini V, Vernerey D
Lien Pubmed
Résumé
We evaluated the value of pre-treatment positron-emission tomography-computed tomography (PET-CT)-based radiomic features in predicting the locoregional progression-free survival (LR-PFS) of patients with inoperable or unresectable oesophageal cancer.
Mots clés
18-FDG PET-CT, chemoradiotherapy, neoadjuvant treatment, oesophageal cancer, predictive factors, radiomics
Référence
Cancers (Basel). 2022 08 22;14(16):